Merck

Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll
Fierce Pharma
Wed, 11/20/24 - 08:41 pm
JNJ
Merck
China
layoffs
Merck says Keytruda injection on par with approved IV version in trial
CNBC
Tue, 11/19/24 - 11:17 am
Merck
Keytruda
IVs
Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug
Pharma Voice
Mon, 11/18/24 - 11:12 am
Merck
Modifi Biosciences
M&A
glioblastoma
brain cancer
Merck pays $588M for bispecific to defend Keytruda’s kingdom from emerging threat
Fierce Biotech
Thu, 11/14/24 - 10:07 am
Merck
Keytruda
bispecific antibodies
LaNova Medicines
Merck, AstraZeneca report positive data for Koselugo in adults
MSN/Seeking Alpha
Tue, 11/12/24 - 08:49 pm
AstraZeneca
Merck
Koselugo
clinical trials
neurofibromatosis
Gardasil's China troubles haunt Merck in Q3, with execs warning of more obstacles ahead
Fierce Pharma
Thu, 10/31/24 - 10:50 pm
Merck
earnings
Gardasil
Keytruda
Moderna and Merck begin trial of mRNA-4157 and Keytruda combination for lung cancer
Clinical Trials Arena
Tue, 10/29/24 - 11:43 am
Moderna Therapeutics
Merck
clinical trials
vaccines
Keytruda
mRNA-4157
non-small cell lung cancer
Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say
Fierce Biotech
Thu, 10/24/24 - 08:27 pm
Arcus Biosciences
kidney cancer
Merck
casdatifan
Welireg
In boon for Pfizer and Merck, CDC panel backs expanded use of pneumococcal vaccines
Fierce Pharma
Wed, 10/23/24 - 10:35 pm
Pfizer
Merck
pneumococcal disease
CDC
vaccines
Merck sets sights on brain cancer with $30M Modifi acquisition
Fierce Biotech
Wed, 10/23/24 - 11:41 am
Merck
M&A
Modifi Biosciences
glioblastoma
brain cancer
Gilead, Merck say HIV combo could be weekly, oral HIV drug
Pharmaphorum
Mon, 10/21/24 - 09:35 am
Gilead Sciences
Merck
HIV
antiretrovirals
clinical trials
islatravir
Sunleca
Merck's RSV antibody for infants shows over 60% efficacy in mid-late-stage study
Reuters
Thu, 10/17/24 - 08:39 pm
Merck
clesrovimab
RSV
clinical trials
infants
Ivonescimab Looking to Rival Merck’s Keytruda in NSCLC with Phase III Trial Enrollment Complete
Xtalks
Thu, 10/10/24 - 10:02 am
Summit Therapeutics
ivonescimab
non-small cell lung cancer
clinical trials
Merck
Keytruda
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Fierce Pharma
Tue, 10/8/24 - 11:19 am
Merck
clinical trials
Keytruda
head and neck cancer
Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end
Fierce Biotech
Thu, 09/26/24 - 11:23 am
Merck
Evaxion Biotech
vaccines
artificial intelligence
Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA
BioSpace
Wed, 09/25/24 - 12:08 pm
Inflation Reduction Act
CMS
drug pricing
Pfizer
Merck
Bristol Myers Squibb
cancer
diabetes
Merck's Keytruda-LAG-3 combo fails to tame tough colorectal cancer in phase 3
Fierce Biotech
Wed, 09/25/24 - 11:47 am
Merck
metastatic colorectal cancer
Keytruda
Keytruda beaten by Summit’s bispecific in NSCLC
Clinical Trials Arena
Fri, 09/20/24 - 11:15 am
Summit Therapeutics
Akeso
Merck
clinical trials
ivonescimab
Keytruda
non-small cell lung cancer
FDA Approves Merck’s Keytruda for First-Line Treatment of Pleural Mesothelioma
BioSpace
Wed, 09/18/24 - 11:16 pm
Merck
Keytruda
mesothelioma
FDA
Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial
Reuters
Tue, 09/17/24 - 09:51 am
Daiichi Sankyo
Merck
patritumab deruxtecan
clinical trials
non-small cell lung cancer

Pages